The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients

PURPOSE: The current investigation examines the potential clinical value and prognostic significance of a systemic immune-inflammation index (SII) in patients with breast cancer. PATIENTS AND METHODS: A total of 477 individuals underwent neoadjuvant chemotherapy, and 308 individuals did not at our c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Mengliu, Chen, Li, Kong, Xiangyi, Wang, Xiangyu, Li, Xingrui, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887616/
https://www.ncbi.nlm.nih.gov/pubmed/35241935
http://dx.doi.org/10.2147/CMAR.S346406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887616/
https://www.ncbi.nlm.nih.gov/pubmed/35241935
http://dx.doi.org/10.2147/CMAR.S346406

Ejemplares similares